Clinical Trials Logo

Clinical Trial Summary

Postoperative ileus (POI) is a common clinical condition after abdominal surgical procedure, leading to increased patient morbidity and prolonged hospitalisation.The mechanism of POI is not very clear until now. At the end of the 20th century, the inflammatory-mediated ileus hypothesis was introduced. But the initial trigger of the inflammatory cascade is unclear.Previous study demonstrate a clear association between colonic transit time, gut microbiota composition and urinary metabolic phenotype. Here the investigators suggest that the perioperative gut microbiota may contribute to POI.


Clinical Trial Description

Postoperative ileus (POI) is a common clinical condition after abdominal surgical procedure, leading to increased patient morbidity and prolonged hospitalisation.

The clinical manifestations include abdominal distension, nausea, vomiting and the inability to pass stools or tolerate a solid diet. In addition to the discomfort experienced by patients, postoperative ileus is also an important risk factor for complications such as wound dehiscence and pulmonary and thromboembolic complications. Ileus was found to be an important predictor of extended postoperative hospital stays and costs in patients undergoing colectomy.

The mechanism of POI is not very clear until now. At the end of the 20th century, the inflammatory-mediated ileus hypothesis was introduced. But the initial trigger of the inflammatory cascade is unclear The innate immune system recognises two large classes of macromolecules: first, those related to pathogens or pathogen-associated molecular patterns (PAMPs), and secondly, molecules released in response to cell damage or damage-associated molecular patterns (DAMPs). The prototype of PAMPs is lipopolysaccharide (LPS), a constituent of the Gram-negative bacterial cell wall. Translocation of microbial products into the intestinal tissue is a well-documented feature in POI. Previous study demonstrate a clear association between colonic transit time, gut microbiota composition and urinary metabolic phenotype. Here the investigators suggest that the perioperative microbiome may contribute to POI. This study apply NGS(next generation sequencing) technique to analyse the composition of the perioperative gut microbiota of CRC(colorectal cancer) patients, then analysis the relationship between the dynamic variation of gut microbiota and POI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04009954
Study type Observational
Source First Affiliated Hospital of Harbin Medical University
Contact Yunwei Wei, professor
Phone +86045185553099
Email hydwyw11@hotmail.com
Status Recruiting
Phase
Start date April 1, 2019
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Terminated NCT00443040 - Asimadoline for the Treatment of Post-Operative Ileus Phase 2
Recruiting NCT02673671 - G-Tech Feasibility Study for Early Detection of a Post-op Ileus
Terminated NCT01662115 - Nicotine Gum Recovery After Colorectal Surgery Phase 4
Completed NCT01869231 - Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus N/A